147 related articles for article (PubMed ID: 24946975)
1. Dysplasia-like epithelial atypia in ischemic bowel disease.
Abraham SC; Taggart MW; Loftus EV; Wu TT
Hum Pathol; 2014 Jul; 45(7):1348-57. PubMed ID: 24946975
[TBL] [Abstract][Full Text] [Related]
2. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma.
Sato A; MacHinami R
Pathol Int; 1999 Oct; 49(10):858-68. PubMed ID: 10571818
[TBL] [Abstract][Full Text] [Related]
3. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
B Brahim E; Mrabet A; Jouini R; Koubaa W; B Sidhom R; Elloumi H; Chadli A
Arab J Gastroenterol; 2016 Sep; 17(3):121-126. PubMed ID: 27567189
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.
Gui X; Liu S; Yan Y; Gao Z
World J Gastroenterol; 2013 Jul; 19(28):4504-10. PubMed ID: 23901225
[TBL] [Abstract][Full Text] [Related]
6. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
7. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
[TBL] [Abstract][Full Text] [Related]
8. Gastric metaplasia as a precursor of nonconventional dysplasia in inflammatory bowel disease.
Musulen E; Gené M; Cuatrecasas M; Amat I; Veiga JA; Fernández-Aceñero MJ; Chimisana VF; Tarragona J; Jurado I; Fernández-Victoria R; Martínez-Ciarpaglini C; Alenda González C; Zac C; Fernández-Figueras MT; Esteller M
Hum Pathol; 2024 Jan; 143():50-61. PubMed ID: 38000679
[TBL] [Abstract][Full Text] [Related]
9. Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma.
Fogt F; Vortmeyer AO; Goldman H; Giordano TJ; Merino MJ; Zhuang Z
Hum Pathol; 1998 Feb; 29(2):131-6. PubMed ID: 9490271
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis.
Sjöqvist U; Ost A; Löfberg R
Int J Colorectal Dis; 1999 Apr; 14(2):107-13. PubMed ID: 10367256
[TBL] [Abstract][Full Text] [Related]
11. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
12. COX-2 and Ki-67 immunohistochemical markers in the assessment of long-standing ulcerative colitis associated dysplasia.
Frăţilă OC; Iliaş TI
Rom J Morphol Embryol; 2013; 54(1):143-9. PubMed ID: 23529322
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia.
Wong NA; Mayer NJ; MacKell S; Gilmour HM; Harrison DJ
Histopathology; 2000 Aug; 37(2):108-14. PubMed ID: 10931232
[TBL] [Abstract][Full Text] [Related]
14. Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation.
Risques RA; Lai LA; Himmetoglu C; Ebaee A; Li L; Feng Z; Bronner MP; Al-Lahham B; Kowdley KV; Lindor KD; Rabinovitch PS; Brentnall TA
Cancer Res; 2011 Mar; 71(5):1669-79. PubMed ID: 21363920
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of colonic dysplasia-like epithelial atypia in murine colitis.
Randall-Demllo S; Fernando R; Brain T; Sohal SS; Cook AL; Guven N; Kunde D; Spring K; Eri R
World J Gastroenterol; 2016 Oct; 22(37):8334-8348. PubMed ID: 27729740
[TBL] [Abstract][Full Text] [Related]
16. Assessment of dysplasia, mucosal mucins, p53 protein expression, and DNA content in ulcerative colitis patients with colectomy and ileorectal anastomosis.
Navratil E; Stettler C; Paul G; Vilotte J; Vissuzaine C; Mignon M; Potet F
Scand J Gastroenterol; 1995 Apr; 30(4):361-6. PubMed ID: 7610353
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein: early marker in the carcinogenesis of ulcerative colitis-associated colorectal carcinoma.
Bruewer M; Schmid KW; Krieglstein CF; Senninger N; Schuermann G
World J Surg; 2002 Jun; 26(6):726-31. PubMed ID: 12053227
[TBL] [Abstract][Full Text] [Related]
18. Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis.
van Schaik FD; Oldenburg B; Offerhaus GJ; Schipper ME; Vleggaar FP; Siersema PD; van Oijen MG; Ten Kate FJ
Inflamm Bowel Dis; 2012 Mar; 18(3):480-8. PubMed ID: 21509910
[TBL] [Abstract][Full Text] [Related]
19. Goblet cell status in idiopathic ulcerative colitis--implication in surveillance program.
Vaiphei K; Saha M; Sharma BC; Bhasin DK; Singh K
Indian J Pathol Microbiol; 2004 Jan; 47(1):16-21. PubMed ID: 15471116
[TBL] [Abstract][Full Text] [Related]
20. Dysplastic Progression to Adenocarcinoma is Equivalent in Ulcerative Colitis and Crohn's Disease.
Lightner AL; Vogler S; McMichael J; Jia X; Regueiro M; Qazi T; Steele SR
J Crohns Colitis; 2021 Jan; 15(1):24-34. PubMed ID: 32592468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
